TLDR
- UNH reached a fresh 52-week peak of $404.14 midweek, surging approximately 30% in the last 30 days
- First quarter revenues totaled $111.7 billion, representing a 2% annual increase, while adjusted earnings per share exceeded forecasts at $7.23
- UnitedHealthcare saw operating margin expansion from 6.2% to 6.6% during the first quarter
- The company’s Medical Care Ratio decreased to 83.9% in Q1, a substantial decline from the previous quarter’s 88.9%
- Strategic membership reduction of 1.3 million Medicare Advantage enrollees for 2026 aimed at preserving profitability
Shares of UnitedHealth Group (UNH) touched a new 52-week peak at $404.14 during Wednesday’s trading session, completing an impressive rally that has propelled the stock upward by approximately 30% throughout the last month.
UnitedHealth Group Incorporated, UNH
Since the start of the year, UNH has advanced roughly 21%. Looking at the trailing twelve-month period, the stock has delivered gains of about 29%.
This upward momentum comes after a challenging beginning to 2025. Between January and late March, shares tumbled from $336 down to $259—representing a decline of approximately 23%.
The turnaround commenced following UnitedHealth‘s late April release of first quarter financial results, which surpassed Wall Street estimates and featured an upward revision to full-year guidance.
First quarter revenues reached $111.7 billion, marking a 2% year-over-year gain. Adjusted earnings per share landed at $7.23, exceeding analyst projections. On a reported basis, EPS stood at $6.90.
UnitedHealthcare’s operating margin expanded from 6.2% to 6.6%, representing a small yet significant enhancement for an organization navigating structural changes.
Medicare Advantage Continues to Present Challenges
The Medicare Advantage program has emerged as one of the most prominent headwinds facing UNH. Federal reimbursement levels have failed to match escalating program expenses, creating margin compression in recent years.
In response, UnitedHealth reduced its Medicare Advantage enrollment by 1.3 million individuals for 2026. While a challenging decision, leadership characterized the action as essential for maintaining long-term financial health.
The results are becoming evident in financial metrics. UnitedHealth’s Medical Care Ratio—representing the portion of premium revenue allocated to claims payments—dropped to 83.9% in Q1, compared with 88.9% during Q4 2025.
This represents a substantial single-quarter improvement and indicates that the enrollment reductions are already yielding positive effects on the company’s cost base.
The Year Started on Uncertain Footing
The opening months of 2025 proved turbulent. UnitedHealth experienced a significant selloff in early January following disappointing Q4 2024 results and a Centers for Medicare & Medicaid Services announcement regarding Medicare Advantage payment rate increases that fell short of market expectations.
The organization has also navigated executive transitions and faces continuing antitrust scrutiny. While these concerns remain unresolved, market participants currently appear willing to focus on operational performance instead.
At its current valuation near $400 per share, UNH offers a dividend yield of approximately 2.3%, while commanding a market capitalization around $360 billion.
The stock’s 52-week trading range extends from $234.60 to $404.15—with Wednesday’s peak matching the upper boundary of that range.
Wednesday’s trading volume registered around 4.8 million shares, falling short of the 8.5 million average, indicating the advance occurred without unusually elevated activity.
UNH most recently changed hands at $400.38 based on the latest Wednesday quotation.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
